EX-1.2 3 d381653dex12.htm FORM OF DEBT-FOR-EQUITY EXCHANGE AGREEMENT DEBT-FOR- EQUITY EXCHANGE AGREEMENTEquity Exchange Agreement • May 5th, 2020 • New York
Contract Type FiledMay 5th, 2020 JurisdictionDEBT-FOR-EQUITY EXCHANGE AGREEMENT dated as of [ ], 2013 (this “Agreement”), among PFIZER INC., a Delaware corporation (“Pfizer”), J.P. MORGAN SECURITIES LLC, MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED and MORGAN STANLEY & CO. LLC (collectively, the “Investment Entities”), and, solely with respect to Sections 4(b) and 6 through 16 hereof, ZOETIS INC., a Delaware corporation and a direct, wholly owned subsidiary of Pfizer (“Zoetis”).
DEBT-FOR-EQUITY EXCHANGE AGREEMENTEquity Exchange Agreement • January 29th, 2013 • Zoetis Inc. • Pharmaceutical preparations • New York
Contract Type FiledJanuary 29th, 2013 Company Industry JurisdictionDEBT-FOR-EQUITY EXCHANGE AGREEMENT dated as of [ ], 2013 (this “Agreement”), among PFIZER INC., a Delaware corporation (“Pfizer”), J.P. MORGAN SECURITIES LLC, MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED and MORGAN STANLEY & CO. LLC (collectively, the “Investment Entities”), and, solely with respect to Sections 4(b) and 6 through 16 hereof, ZOETIS INC., a Delaware corporation and a direct, wholly owned subsidiary of Pfizer (“Zoetis”).